Vascularity Change and Tumor Response to Neoadjuvant Chemotherapy for Advanced Breast Cancer

Ultrasound in Medicine and Biology

Volumn 34, Issue 6, 2008, Pages 857-866

  Kuo, Wen Hung ^a,b   Chen, Chiung Nien ^a,b,c   Hsieh, Fon Jou ^a,b,d   Shyu, Ming Kwang ^a   Chang, Li Yun ^a   Lee, Po Huang ^a,b   Liu, Li Yu D ^b   Cheng, Chia Hsien ^a   Wang, Jane ^a   Chang, King Jen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c RESEARCH CENTER FOR APPLIED SCIENCES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Advanced breast cancer (ABC); Angiogenesis; Increasing in vascularity; Neoadjuvant chemotherapy; Power Doppler sonography; Vascularity index (VI)

Indexed keywords

DISEASES; DOPPLER EFFECT; ONCOLOGY; TUMORS; ULTRASONOGRAPHY;

ADVANCED BREAST CANCER (ABC); ANGIOGENESIS; INCREASING IN VASCULARITY; NEOADJUVANT CHEMOTHERAPY; POWER DOPPLER SONOGRAPHY; VASCULARITY INDEX (VI);

CHEMOTHERAPY;

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; NAVELBINE; PACLITAXEL; PHYXOL;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; ECHOMAMMOGRAPHY; HUMAN; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, MAMMARY;

EID: 43849085919     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2007.11.011     Document Type: Article

References (41)

1. Birdwell R.L., Ikeda D.M., Jeffrey S.S., and Jeffrey Jr. R.B. Preliminary experience with power Doppler imaging of solid breast masses. Am J Roentgenol 169 (1997) 703-707
2. Bonadonna G., Valagussa P., Brambilla C., Moliterni A., Zambetti M., and Ferrari L. Adjuvant and neoadjuvant treatment of breast cancers with chemotherapy and endocrine therapy. Semin Oncol 18 (1991) 515-524
3. Boonjunwetwat D., Prueksadee J., Sampatanukul P., and Chatamra K. Does color Doppler ultrasound vascularity predict the response to neoadjuvant chemotherapy in breast cancer?. J Med Assoc Thai 88 10 (2005) 1367-1372
4. Caruso G., Cucciarre S., Lo Bello M., Mercurio G., Candela F., Cianchino C., and Lagalla R. Neoadjuvant intralesional chemotherapy for breast neoplasm in advanced stage. Assessment of its efficacy with Doppler color. Radiol Med (Torino) 89 5 (1995) 613-618
5. Chao T.C., Lo Y.F., Chen S.C., and Chen M.F. Color Doppler ultrasound in benign and malignant breast tumors. Breast Cancer Res Treat 57 2 (1999) 193-199
6. Chen C.N., Cheng Y.M., Liang J.T., Lee P.H., Hsieh F.J., Yuan R.H., Wang S.M., Chang M.F., and Chang K.J. Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res 60 (2000) 2892-2897
7. Chen H.X., Mooney M., Boron M., Vena D., Mosby K., Grochow L., Jaffe C., Rubinstein L., Zwiebel J., and Kaplan R.S. Bevacizumab plus 5-FU/leucovorin for advanced colorectal cancer that progressed after standard chemotherapies: An NCI Treatment Referral Center Trial (TRC-0301). J Clin Oncol 22 14S (2004) 248s
8. Cheng W.F., Lee C.N., Chu J.S., Chen C.A., Chen T.M., Shau W.Y., Hsieh C.Y., and Hsieh F.J. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer (Phila) 85 (1999) 651-657
9. Clahsen P.C., van de Velde C.J., Julien J.P., Floiras J.L., Delozier T., Mignolet F.Y., and Sahmoud T.M. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 14 3 (1996) 745-753
10. Cosgrove D.O., Bamber J.C., Davey J.B., McKinna J.A., and Sinnett H.D. Color Doppler signals from breast tumors. Work in progress. Radiology 176 (1990) 175-180
11. Cosgrove D.O., Kedar R.P., Bamber J.C., al-Murrani B., Davey J.B., Fisher C., McKinna J.A., Svensson W.E., Tohno E., and Vagios E. Breast diseases: Color Doppler US in differential diagnosis. Radiology 189 (1993) 99-104
12. Dixon J.M., Walsh J., Paterson D., and Chetty U. Color Doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg 79 (1992) 259-260
13. Folkman J., Long D., and Becker F. Growth and metastasis of tumor in organ culture. Cancer (Phila) 16 (1963) 453-457
14. Furstenberger G., von Moos R., Lucas R., Thurlimann B., Senn H.J., Hamacher J., and Boneberg E.M. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 94 4 (2006) 524-531
15. Hayward J.L., Carbone P.P., Heusen J.C., Kumaoka S., Segaloff A., and Rubens R.D. Assessment of response to therapy in advanced breast cancer. Br J Cancer 35 3 (1977) 292-298
16. Hsu C., Chen C.N., Chen L.T., Wu C.Y., Hsieh F.J., and Cheng A.L. Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors. Radiology 235 2 (2005) 509-516
17. Huber S., Medl M., Helbich T., Taucher S., Wagner T., Rudas M., Zuna I., and Delorme S. Locally advanced breast carcinoma: Computer assisted semiquantitative analysis of color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy (work in progress). J Ultrasound Med 19 (2000) 601-607
18. Kedar R.P., Cosgrove D.O., Smith I.E., Mansi J.L., and Bamber J.C. Breast carcinoma: Measurement of tumor response to primary medical therapy with color Doppler flow imaging. Radiology 190 (1994) 825-830
19. Kook S.H., Park H.W., Lee Y.R., Lee Y.U., Pae W.K., and Park Y.L. Evaluation of solid breast tumors with power Doppler sonography. J Clin Ultrasound 27 (1999) 231-237
20. Lagalla R., Caruso G., and Finazzo M. Monitoring treatment response with color and power Doppler. Eur J Radiol 27 Suppl 2 (1998) S149-S156
21. Less J.R., Skalak T.C., Sevick E.M., and Jain R.K. Microvascular architecture in a mammary carcinoma: Branching patterns and vessel dimensions. Cancer Res 51 (1991) 265-273
22. Mamounas E.P. Overview of National Surgical Adjuvant Breast Project neoadjuvant chemotherapy studies. Sem Oncol Suppl 3 (1998) 31-35
23. Martinoli C., Pretolesi F., Crespi G., Bianchi S., Gandolfo N., Valle M., and Derchi L.E. Power Doppler sonography: Clinical applications. Eur J Radiol 27 Suppl 2 (1998) S133-S140
24. Miller K.D. E2100: A phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer. Clin Breast Cancer 3 6 (2003) 421-422
25. Miller K.D., Chap L.I., Holmes F.A., Cobleigh M.A., Marcom P.K., Fehrenbacher L., Dickler M., Overmoyer B.A., Reimann J.D., Sing A.P., Langmuir V., and Rugo H.S. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23 (2005) 792-799
26. Milz P., Lienemann A., Kessler M., and Reiser M. Evaluation of breast tumors by power Doppler sonography. Eur Radiol 11 (2001) 547-554
27. Raza S., and Baum J.K. Solid breast tumors: Evaluation with power Doppler US. Radiology 203 (1997) 164-168
28. Roberrto L., Giuseppe C., and Mario F. Monitoring treatment response with color and power Doppler. Eur J Radiol 28 suppl (1998) S149-S156
29. Roubidoux M.A., LeCarpentier G.L., Fowlkes J.B., Bartz B., Pai D., Gordon S.P., Schott A.F., Johnson T.D., and Carson P.L. Sonographic evaluation of early-stage breast cancers that undergo neoadjuvant chemotherapy. J Ultrasound Med 24 (2005) 885-895
30. Rubin J.M., Bude R.O., Carson P.L., Bree R.L., and Adler R.S. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US. Radiology 190 (1994) 853-856
31. Shaked Y., Ciarrocchi A., Franco M., Lee C.R., Man S., Cheung A.M., Hicklin D.J., Chaplin D., Foster F.S., Benezra R., and Kerbel R.S. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313 5794 (2006) 1785-1787
32. Singh S., Pradhan S., Shukla R.C., Ansari M.A., and Kumar A. Color Doppler ultrasound as an objective assessment tool for chemotherapeutic response in advanced breast cancer. Breast Cancer 12 1 (2005) 45-51
33. Smith I.C., Heys S.D., Hutcheon A.W., Miller I.D., Payne S., Gilbert F.J., Ah-See A.K., Eremin O., Walker L.G., Sarkar T.K., Eggleton S.P., and Ogston K.N. Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel. J Clin Oncol 20 6 (2002) 1456-1466
34. Smith I.E. Primary (neoadjuvant) medical therapy. In: Powles T.J., and Smith I.E. (Eds). Medical Management of Breast Cancer (1991), Martin Dunitz, London 259-265
35. Taylor K.J., Ramos I., Carter D., Morse S.S., Snower D., and Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 166 1 Pt 1 (1988) 57-62
36. Toi M., Kashitani L., and Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55 (1993) 371-374
37. Vallone P., D'Angelo R., Filice S., Petrosino T., Rinaldo M., De Chiara A., and Gallipoli A. Color-doppler using contrast medium in evaluating the response to neoadjuvant treatment in patients with locally advanced breast carcinoma. Anticancer Res 25 (2005) 595-599
38. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
39. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., Meli S., and Gasparini G. Turmor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Nat Cancer Inst 84 (1992) 1875-1887
40. Wu C.H., Hsu M.M., Chang Y.L., and Hsieh F.J. Vascular pathology of malignant cervical lymphadenopathy. Cancer (Phila) 83 (1998) 1189-1196
41. Yang W.T., Tse G.M., Lam P.K., Metreweli C., and Chang J. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med 21 (2002) 1227-1235